Pages that link to "Q28240014"
Jump to navigation
Jump to search
The following pages link to Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2 (Q28240014):
Displaying 50 items.
- Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism (Q24681426) (← links)
- Serum deprivation and re-addition: effects on cyclooxygenase inhibitor sensitivity in cultured glia (Q28193300) (← links)
- Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats (Q28195213) (← links)
- Methamphetamine-induced striatal dopamine neurotoxicity and cyclooxygenase-2 protein expression in BALB/c mice (Q28372015) (← links)
- Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus (Q28374549) (← links)
- Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats (Q28581714) (← links)
- What animal models have taught us about the treatment of acute stroke and brain protection (Q30620998) (← links)
- Cyclooxygenase-2 mRNA expression is associated with c-fos mRNA expression and transient water ADC reduction detected with diffusion MRI during acute focal ischemia in rats (Q30762687) (← links)
- Glucocorticoid treatment in an ischaemic-like excitotoxic model of periventricular leucomalacia in mice (Q30852322) (← links)
- NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data (Q31135314) (← links)
- The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus (Q31900758) (← links)
- Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition (Q32034876) (← links)
- Differential effects of ethanol on the expression of cyclo-oxygenase in cultured cortical astrocytes and neurons (Q32134336) (← links)
- Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology. (Q33204952) (← links)
- Chronic intracerebroventricular delivery of the secretory phospholipase A2 inhibitor, 12-epi-scalaradial, does not improve outcome after focal cerebral ischemia-reperfusion in rats (Q33252112) (← links)
- Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells. (Q33443011) (← links)
- Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead (Q33534037) (← links)
- Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia (Q33567203) (← links)
- Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicity (Q33730643) (← links)
- Emerging roles of PGE2 receptors in models of neurological disease (Q33756150) (← links)
- Signalling mechanisms involved in P2Y receptor-mediated reactive astrogliosis. (Q33768457) (← links)
- Dietary modulation of prostanoid synthesis in the aging process: role of cyclooxygenase-2. (Q33828732) (← links)
- Neuronal and nonneuronal COX-2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge (Q33859381) (← links)
- Spreading depression-induced cyclooxygenase-2 expression in the cortex (Q33975184) (← links)
- Multiple molecular penumbras after focal cerebral ischemia (Q33977693) (← links)
- Cytosolic phospholipase A2alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice (Q34071481) (← links)
- A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma (Q34377317) (← links)
- Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. (Q34661712) (← links)
- Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury (Q34830891) (← links)
- Neural controls of prostaglandin 2 pyrogenic, tachycardic, and anorexic actions are anatomically distributed (Q35001402) (← links)
- Central nervous system agents for ischemic stroke: neuroprotection mechanisms (Q35137635) (← links)
- Differential effects of treadmill exercise on cyclooxygenase-2 in the rat hippocampus at early and chronic stages of diabetes (Q35285469) (← links)
- Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells (Q35556908) (← links)
- Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition (Q35654607) (← links)
- Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial (Q35852208) (← links)
- Magnesium sulfate and nimesulide have synergistic effects on rescuing brain damage after transient focal ischemia. (Q35908888) (← links)
- Contribution of prostanoid signaling to the evolution of spreading depolarization and the associated cerebral blood flow response. (Q36099329) (← links)
- Investigational anti-inflammatory agents for the treatment of ischaemic brain injury (Q36120766) (← links)
- Cortical spreading depression modifies components of the inflammatory cascade (Q36217311) (← links)
- Focus on therapy of primary stabbing headache (Q36261220) (← links)
- The role of antioxidants in models of inflammation: emphasis on L-arginine and arachidonic acid metabolism. (Q36301668) (← links)
- Bilateral common carotid artery ligation transiently changes brain lipid metabolism in rats (Q36338190) (← links)
- Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression (Q36368615) (← links)
- Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease? (Q36396392) (← links)
- Lipid signaling and synaptic plasticity (Q36587189) (← links)
- A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window (Q36678875) (← links)
- Cyclooxygenase-2 in synaptic signaling (Q36922736) (← links)
- Prostaglandin E2 depresses solitary tract-mediated synaptic transmission in the nucleus tractus solitarius (Q36925735) (← links)
- Function of COX-2 and prostaglandins in neurological disease (Q36954203) (← links)
- Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain (Q36998124) (← links)